SARAJEVO, August 25 (Reuters) - U.S.-based generic drug maker Alvogen Inc is mulling the acquisition of a government stake in Bosnia’s top drug firm Bosnalijek BSNL.SJ as a step to becoming a leading drug company in the region.
SARAJEVO, August 25 (Reuters) - U.S.-based generic drug maker Alvogen Inc is mulling the acquisition of a government stake in Bosnia’s top drug firm Bosnalijek BSNL.SJ as a step to becoming a leading drug company in the region.
